CN Patent

CN101035759A — N－(4－氟苄基)－n－(1－甲基哌啶－4－基)－n’－(4－(2－甲基丙氧基)苯基甲基)脲及其酒石酸盐的合成和晶形

Assigned to Acadia Pharmaceuticals Inc · Expires 2007-09-12 · 19y expired

What this patent protects

本发明公开了合成式(I)的N－(4－氟苄基)－N－(1－甲基哌啶－4－基)－N’－(4－(2－甲基丙氧基)－苯基甲基)脲的方法。本发明还公开了N－(4－氟苄基)－N－(1－甲基哌啶－4－基)－N’－(4－(2－甲基丙氧基)－苯基甲基)脲的半酒石酸盐和得到该盐的方法。还公开了N－(4－氟苄基)－N－(1－甲基哌啶－4－基)－N’－(4－(2－甲基丙氧基)－苯基甲基)脲及其半酒石酸盐的多种晶形，所述晶形包括多种多晶型物和溶剂化物。

USPTO Abstract

本发明公开了合成式(I)的N－(4－氟苄基)－N－(1－甲基哌啶－4－基)－N’－(4－(2－甲基丙氧基)－苯基甲基)脲的方法。本发明还公开了N－(4－氟苄基)－N－(1－甲基哌啶－4－基)－N’－(4－(2－甲基丙氧基)－苯基甲基)脲的半酒石酸盐和得到该盐的方法。还公开了N－(4－氟苄基)－N－(1－甲基哌啶－4－基)－N’－(4－(2－甲基丙氧基)－苯基甲基)脲及其半酒石酸盐的多种晶形，所述晶形包括多种多晶型物和溶剂化物。

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: CN101035759A
Jurisdiction: CN
Classification: —
Expires: 2007-09-12
Drug substance claim: No
Drug product claim: No
Assignee: Acadia Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.